Crossmark

[Translated article] Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1016/j.farma.2024.10.001

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

López Sánchez, Piedad

Palanques Pastor, Tomás

Ibarra Barrueta, Olatz

Ramírez Herráiz, Esther

Casellas Gibert, Míriam

Monte Boquet, Emilio
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2024-10-03
More Information

This article is maintained by: Elsevier

Article Title: [Translated article] Analysis of the situation of pharmaceutical care for patients with immune-mediated inflammatory diseases before and after the COVID-19 pandemic

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2024.10.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.farma.2024.05.005

Content Type: article

Copyright: © 2024 Sociedad Española de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below